These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 25771391)
21. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease. Takahara T; Shimizu M; Nakagishi Y; Kinjo N; Yachie A Rheumatol Int; 2015 Jan; 35(1):81-4. PubMed ID: 24917023 [TBL] [Abstract][Full Text] [Related]
22. Identification of the best cutoff points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis. Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Likhacheva TS; Isupova EA; Glebova NI; Kuchinskaya EM; Balbotkina EV; Buchinskaya NV; Kalashnikova OV; Chasnyk VG Semin Arthritis Rheum; 2015 Feb; 44(4):417-22. PubMed ID: 25300700 [TBL] [Abstract][Full Text] [Related]
23. Macrophage activation syndrome in Kawasaki disease: more common than we thought? Wang W; Gong F; Zhu W; Fu S; Zhang Q Semin Arthritis Rheum; 2015 Feb; 44(4):405-10. PubMed ID: 25200945 [TBL] [Abstract][Full Text] [Related]
24. Impact of Kawasaki disease on juvenile idiopathic arthritis in real-world patients: A population-based cohort study. Liao LC; Fu YH; Chuang CM; Liao PL; Wei JC; Fu YC Front Immunol; 2022; 13():1025553. PubMed ID: 36569831 [TBL] [Abstract][Full Text] [Related]
25. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis. Juneja M; Jain R; Mishra D Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084 [TBL] [Abstract][Full Text] [Related]
26. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. Allantaz F; Chaussabel D; Stichweh D; Bennett L; Allman W; Mejias A; Ardura M; Chung W; Smith E; Wise C; Palucka K; Ramilo O; Punaro M; Banchereau J; Pascual V J Exp Med; 2007 Sep; 204(9):2131-44. PubMed ID: 17724127 [TBL] [Abstract][Full Text] [Related]
27. Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis. Baris HE; Anderson E; Sozeri B; Dedeoglu F Clin Rheumatol; 2018 Dec; 37(12):3263-3273. PubMed ID: 30238379 [TBL] [Abstract][Full Text] [Related]
28. [Value of serum ferritin in measuring the activation and prognosis in systemic onset juvenile idiopathic arthritis]. Zhou YF; Li CF; Wang J; Han TX; Kuang WY; Deng JH; Zhang JM; Tan XH Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2487-9. PubMed ID: 24300271 [TBL] [Abstract][Full Text] [Related]
29. [Macrophage activation syndrome in children with rheumatic disorders: a retrospective study on 6 patients]. Hu J; Li CW; Ma JJ; Yin J; Wang XM; Huang WY; Zhang YM Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):818-23. PubMed ID: 17274867 [TBL] [Abstract][Full Text] [Related]
31. Anakinra and hepatotoxicity in pediatric rheumatology: a case series. Martins FR; Azevedo AC; Ganhão S; Aguiar F; Rodrigues M; Brito I Pediatr Rheumatol Online J; 2023 Oct; 21(1):112. PubMed ID: 37803456 [TBL] [Abstract][Full Text] [Related]
32. Macrophage activation syndrome in pediatrics: 10 years data from an Indian center. Pal P; Bathia J; Giri PP; Roy M; Nandi A Int J Rheum Dis; 2020 Oct; 23(10):1412-1416. PubMed ID: 32666639 [TBL] [Abstract][Full Text] [Related]
33. Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. Heuclin T; Dubos F; Hue V; Godart F; Francart C; Vincent P; ; Martinot A J Pediatr; 2009 Nov; 155(5):695-9.e1. PubMed ID: 19595368 [TBL] [Abstract][Full Text] [Related]
34. Clinical and Laboratory Profile of Macrophage Activation Syndrome in Kawasaki Disease: A Single Centre Cross-Sectional Study. Maheshwari A; Gulati S; Kakkar V; Kavya DR; Aggarwal M; Basu S; Mahto D Indian Pediatr; 2024 Aug; 61(8):723-729. PubMed ID: 38859648 [TBL] [Abstract][Full Text] [Related]
35. Kawasaki disease in children and adolescents: clinical data of Kawasaki patients in a western region (Tyrol) of Austria from 2003-2012. Binder E; Griesmaier E; Giner T; Sailer-Höck M; Brunner J Pediatr Rheumatol Online J; 2014 Sep; 12(1):37. PubMed ID: 27643389 [TBL] [Abstract][Full Text] [Related]
36. Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review. Manlhiot C; O'Shea S; Bernknopf B; LaBelle M; Chahal N; Dillenburg RF; Lai LS; Bock D; Lew B; Masood S; Mathew M; McCrindle BW Can J Cardiol; 2018 Mar; 34(3):303-309. PubMed ID: 29395706 [TBL] [Abstract][Full Text] [Related]
37. Kawasaki disease in Sicily: clinical description and markers of disease severity. Maggio MC; Corsello G; Prinzi E; Cimaz R Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720 [TBL] [Abstract][Full Text] [Related]
38. The epidemiology and clinical features of Kawasaki disease in Australia. Saundankar J; Yim D; Itotoh B; Payne R; Maslin K; Jape G; Ramsay J; Kothari D; Cheng A; Burgner D Pediatrics; 2014 Apr; 133(4):e1009-14. PubMed ID: 24685950 [TBL] [Abstract][Full Text] [Related]
39. [Symptoms, diagnosis and characteristic abnormalities in the coronary arteries in Kawasaki disease in children]. Kowalczyk M; Turska-Kmieć A; Ziółkowska L; Raszek M; Kawalec W Med Wieku Rozwoj; 2010; 14(4):344-9. PubMed ID: 21462478 [TBL] [Abstract][Full Text] [Related]
40. The incidence of macrophage activation syndrome in children with rheumatic disorders. Moradinejad MH; Ziaee V Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]